Why did HIMS stock fall more than the market?
Several factors could contribute, including negative revisions in analyst estimates (reflected in its Zacks Rank of #4), and valuation metrics suggesting the stock is trading at a premium.
Yanuki
ARTICLE DETAIL
Hims & Hers (HIMS) Stock Falls More Than Broader Market: What's Happening? | Is Tesla Stock Going to $1,000? | Why the Nasdaq Is Holding Up Better Amid Geopolitical Tensions | Walmart vs BJ's Wholesale: Which Retailer Is a Better Buy? | Institutional Investors Increase Holdings in Invesco QQQ | ExxonMobil (XOM) Stock Analysis: Retail Investors and Market Trends in 2026 | Warren Buffett's Oil Bet: Analyzing Occidental Petroleum (OXY) and the Energy Market in 2026 | Tesla's Risks and Investment Alternatives | Micron Stock: Supply Tightness and Growth Potential in 2026 | Hims & Hers (HIMS) Stock Falls More Than Broader Market: What's Happening? | Is Tesla Stock Going to $1,000? | Why the Nasdaq Is Holding Up Better Amid Geopolitical Tensions | Walmart vs BJ's Wholesale: Which Retailer Is a Better Buy? | Institutional Investors Increase Holdings in Invesco QQQ | ExxonMobil (XOM) Stock Analysis: Retail Investors and Market Trends in 2026 | Warren Buffett's Oil Bet: Analyzing Occidental Petroleum (OXY) and the Energy Market in 2026 | Tesla's Risks and Investment Alternatives | Micron Stock: Supply Tightness and Growth Potential in 2026
Finance / Stocks
Hims & Hers (HIMS) Stock Falls More Than Broader Market: What's Happening?
Hims & Hers Health, Inc. (HIMS) recently experienced a stock decline that surpassed the losses seen in the broader market. This article breaks down the factors influencing this downturn and what investors should consider.
Key Insights
- HIMS stock closed at $59.15, a -5.75% change from the previous day, while the S&P 500 only lost 0.63%. Why does this matter? This underperformance signals specific challenges or investor concerns related to HIMS.
- Despite the recent drop, HIMS shares had gained 24.65% in the past month, outperforming both the Medical sector and the S&P 500. This highlights the stock's volatility and the importance of considering longer-term trends.
- The company is set to release its earnings report on November 3, 2025, with forecasts indicating an EPS of $0.09 (50% increase year-over-year) and revenue of $581.61 million (44.84% increase year-over-year). Investors are closely watching these figures as indicators of future performance.
- Full-year forecasts predict earnings of $0.6 per share and revenue of $2.35 billion, representing significant growth compared to the previous year (+122.22% and +59.03%, respectively). These projections suggest strong potential if the company meets expectations.
In-Depth Analysis
Hims & Hers Health, Inc. operates within the Medical Info Systems industry, which currently ranks in the top 38% of all industries according to the Zacks Industry Rank. However, the company holds a Zacks Rank of #4 (Sell), reflecting recent downward revisions in EPS estimates. This divergence suggests that while the industry is strong, HIMS faces specific headwinds.
**Valuation Metrics:**
- **Forward P/E Ratio:** HIMS has a Forward P/E ratio of 105.22, significantly higher than the industry average of 40.64. This indicates that the stock is trading at a premium compared to its peers.
- **PEG Ratio:** The company's PEG ratio is 4.29, also higher than the Medical Info Systems industry average of 3.33. A higher PEG ratio might suggest that the stock is overvalued relative to its expected earnings growth.
FAQ
When is the next earnings report?
November 3, 2025. Investors are anticipating an EPS of $0.09 and revenue of $581.61 million.
Takeaways
- Monitor HIMS's upcoming earnings report on November 3, 2025, to see if it meets growth expectations.
- Pay attention to analyst estimates and any revisions, as these can significantly impact stock performance.
- Consider the company's valuation metrics, such as its Forward P/E and PEG ratios, in relation to its industry peers.
Discussion
Do you think Hims & Hers can overcome these challenges and meet its growth forecasts? Share your thoughts in the comments below!
Share this article with others who need to stay ahead of this trend!
Sources
Disclaimer
This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.
All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.
This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.
Always do your own research (DYOR) before making any decisions based on the information presented.